文献速递临床生化质量管理与危急值

填补GAPS:验证阴离子间隙测量不确定度估计以用于临床决策

Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making.
PubMed 文献 · Clin Chem Lab Med · 2022-04-20

该研究比较了阴离子间隙(AGAP)的测量不确定度(MU)计算与医生观察到的真实患者结果变异,使用两种不同仪器类型顺序测量AGAP。基于加拿大卡尔加里五家城市三级医院的39,626名受试者的回顾性配对AGAP数据,发现假设无相关性时MU估计更能代表真实患者数据中的总变异。研究提出了一种验证MU计算以指导临床决策并确定分析前贡献的实用方法。

要点

  • 假设无相关性时,AGAP的MU衍生参考变化值(RCV)为5.2-6.1 mmol/L。
  • 假设有相关性时,AGAP的MU衍生RCV为2.6-3.1 mmol/L。
  • 配对数据中AGAP报告值的总观察变异95%置信区间为±6.0 mmol/L。

核心结论

  • 假设无相关性的MU估计更能代表真实患者数据中的总变异。
  • 研究提出了一种验证MU计算以指导临床决策并确定分析前贡献的实用方法。

研究设计与样本

  • 比较MU计算与真实患者结果变异,使用两种不同仪器类型顺序测量AGAP。
  • AGAP由化学或血气分析仪报告的钠、氯和碳酸氢盐计算,采用不同方法和样本类型。
  • MU采用自上而下方法计算,分别假设测量物间无相关性和考虑相关性。
  • 观察性配对AGAP数据来自加拿大卡尔加里五家城市三级医院的回顾性分析样本,n=39,626名受试者。

主要发现

  • 假设无相关性时,两种平台配对样本数据的MU衍生AGAP RCV为5.2-6.1 mmol/L。
  • 假设有相关性时,MU衍生AGAP RCV为2.6-3.1 mmol/L。
  • 配对化学和血气数据中,报告AGAP的总观察变异95%置信区间为±6.0 mmol/L。
  • 假设有相关性时,分析前变异对AGAP观察变异的贡献为2.9-3.5 mmol/L。
  • 假设无相关性时,分析前贡献可忽略(<1.0 mmol/L)。

关键数值与推荐

  • 假设无相关性时,AGAP的MU衍生RCV为5.2-6.1 mmol/L。
  • 假设有相关性时,AGAP的MU衍生RCV为2.6-3.1 mmol/L。
  • 报告AGAP的总观察变异95%置信区间为±6.0 mmol/L。
  • 假设有相关性时,分析前变异贡献为2.9-3.5 mmol/L。
  • 假设无相关性时,分析前贡献<1.0 mmol/L。

临床怎么用

  • 临床决策中应使用假设无相关性的MU估计来解读AGAP结果。
  • 验证MU计算有助于确定分析前变异对AGAP的贡献。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We compare measurement uncertainty (MU) calculations to real patient result variation observed by physicians using as our model anion gap (AGAP) sequentially measured on two different instrument types. An approach for discretely quantifying the pre-analytical contributions and validating AGAP MU estimates for interpretation of patient results is proposed. METHODS: AGAP was calculated from sodium, chloride, and bicarbonate reported from chemistry or blood gas analyzers which employ different methodologies and specimen types. AGAP MU was calculated using a top-down approach both assuming no correlation between measurands and alternatively, including consideration of measurand correlation. MU-derived reference change values (RCV) were calculated between chemistry and blood gas analyzers results. Observational paired AGAP data (n=39,626 subjects) was obtained from retrospectively analyzed specimens from five urban tertiary care hospitals in Calgary, Alberta, Canada. RESULTS: The MU derived AGAP RCV for paired specimen data by the two platforms was 5.2-6.1 mmol/L assuming no correlation and 2.6-3.1 mmol/L assuming correlation. From the paired chemistry and blood gas data, total observed variation on a reported AGAP has a 95% confidence interval of ±6.0 mmol/L. When the MU-derived RCV assuming correlation is directly compared against the observed distribution of patient results, we obtained a pre-analytical variation contribution of 2.9-3.5 mmol/L to the AGAP observed variation. In contrast, assuming no correlation leads to a negligible pre-analytical contribution (<1.0 mmol/L). CONCLUSIONS: MU estimates assuming no correlation are more representative of the total variation seen in real patient data. We present a pragmatic approach for validating an MU calculation to inform clinical decisions and determine the pre-analytical contribution to MU in this system.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Gifford JL, Seiden-Long I. Filling in the GAPS: validation of anion gap (AGAP) measurement uncertainty estimates for use in clinical decision making. Clin Chem Lab Med. 2022. PMID: 35442590. doi:10.1515/cclm-2021-1279

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。